Chemistry: molecular biology and microbiology – Virus or bacteriophage – except for viral vector or...
Patent
1992-10-28
1996-05-28
Jones, W. Gary
Chemistry: molecular biology and microbiology
Virus or bacteriophage, except for viral vector or...
435236, 435239, C12N 700, C12N 702, C12N 704, C12N 708
Patent
active
055210821
ABSTRACT:
New methods for purifying Hepatitis A virus (HAV) are to commercial scale-up and manufacture of specific HAV vaccines, including formalin-inactivated HAV and attenuated HAV.
REFERENCES:
patent: 3919044 (1975-11-01), Melnick et al.
patent: 3994870 (1976-11-01), Neurath
patent: 4164566 (1979-08-01), Provost et al.
patent: 4614793 (1986-09-01), Hughes et al.
patent: 4683294 (1987-07-01), Van Wijnendaele et al.
patent: 4894228 (1990-01-01), Purcell et al.
Maniatis et al Molecular Cloning CSH (1982) pp. 80-81, 458-459.
Wheeler, C. N., et al., Journal of Virology, vol. 58, pp. 307-313, 1986 (May).
Crance, J. M., et al., C. R. Seances Acad. Sci. Paris, Serie III, vol. 293, pp. 693-696, 1981 (Dec.).
Welling, G. W., et al., Journal of Chromatography, vol. 297, pp. 101-109, 1984.
J. A. Lewis et al, Proceedings of the International Symposium on Viral Hepatitis and Liver Disease, pp. 94-97 (1990).
R. Najarian et al., Proc. Natl. Acad. Sci. 82: pp. 2627-2631 (1985).
R. J. Gerety (ed.) Hepatitis A-Academic Press pp. 263-276 (1984).
S. M. Feinstone, Progress in Liver Diseases 8: 299-310 (1986).
A. M. Mijch et al., Seminars in Liver Diseases 6: 42-45 (1986).
C. L. Hornbeck et al., Intervirology 6:309-314 (1976).
S. A. Locarnini et al., Intervirology 10: 300-308 (1978).
G. Siegel et al., J. Virol. 26: 40-47 (1978).
G. Siegl et al., J. Gen. Virol. 57: 331-341 (1981).
G. Siegl et al., Intervirology 22: 218-226 (1984).
J. V. Hughes et al., J. Virol. 52: 465-473 (1984).
C. M. Wheeler et al., J. Virol. 58: 307-313 (1986).
J. R. Ticehurst, Seminars in Liver Disease 6: 46-55 (1986).
P. J. Provost et al., Proc. Soc. Exp. Biol. Med. 106: 213-221 (1979).
P. J. Provost et al., J. Med. Virol. 19: 23-31 (1986).
P. J. Provost et al., Proc. Soc. Exp. Biol. Med. 170: 8-14 (1982).
P. J. Provost et al., J. Med. Virol. 20: 165-175 (1986).
I. M. Kerr et al., J. of Virology 9: 559-561 (1972).
R. R. Rueckert et al., Meth. in Enzymology 78:315-325 (1976).
P. J. Provost et al., 1987 oral presentation given at International Symposium on Viral Hep. and Liver Disease, London, May 26-28 (1987).
Hilleman et al., Hep. A. and B. Vaccines, 34: 385-397 (1982).
Wheeler et al., J. CLin. Microbial; 23: pp. 434-440 (1986).
J. A. Lewis et al., Proceedings of the International Symposium on Viral Hepatitis and Liver Disease, pp. 94-97 (1990).
Luria, et al., General Virol. Wiley & Sons p. 36-53 (1978).
Davis et al., Microbiology, 3rd ed., Harper & Row pp. 1218-1219 (1980).
Philipson, Methods in Virol., vol. 11, pp. 235-244 (1967).
Armstrong Marcy E.
Emini Emilio A.
Lewis John A.
Glesser Joanne M.
Jones W. Gary
Merck & Co. , Inc.
Tran Paul B.
Tribble Jack L.
LandOfFree
Novel process for purification of hepatitis a virions does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Novel process for purification of hepatitis a virions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel process for purification of hepatitis a virions will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-785988